Terran Biosciences has entered into an agreement with Sanofi S.A. for worldwide exclusive rights to develop and commercialize two late-stage CNS pipeline assets.
Category Press Release
Published in Cision
Companies Featured
Terran BiosciencesTerran Biosciences is developing a portfolio of drugs, an imaging device, and a precision medicine platform to treat a variety of neurological and psychiatric illnesses.